首页> 美国卫生研究院文献>Journal of Thoracic Disease >Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness polymeric carriers and antiproliferative drugs

【2h】

Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness polymeric carriers and antiproliferative drugs

机译：超薄支杆药物洗脱支架是否应被视为新型冠状动脉支架批准的新基准？支架支柱厚度聚合物载体和抗增殖药物之间的复杂相互作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Journal of Thoracic Disease
作者
Alessandro Lupi; Alon Schaffer; Angelo Sante Bongo;
展开▼
作者单位

展开▼
年(卷),期 2018(10),2
年度 2018
页码 678–681
总页数 4
原文格式 PDF
正文语种
中图分类呼吸生理学;
关键词

相似文献

外文文献
专利

1. Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs [J] . Alessandro Lupi, Alon Schaffer, Angelo Sante Bongo Journal of Thoracic Disease . 2018,第2期

机译：是否应该将超薄支撑杆药物洗脱支架视为新型冠状动脉支架批准的新基准？支架支柱厚度，聚合物载体和抗增殖药物之间的复杂相互作用
2. Letter by Romaguera et al Regarding Article, "Newer Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials" [J] . Romaguera Rafael, Gomez-Lara Josep, Antoni Gomez-Hospital Joan Circulation: An Official Journal of the American Heart Association . 2019,第17期

机译：Romaguera等人关于文章的信，“更新的超薄支撑药支架与较旧的第二代较厚的支撑支撑冠状动脉疾病：随机试验的Meta分析”
3. Response by Bangalore to Letter Regarding Article, "Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials" [J] . Bangalore Sripal Circulation: An Official Journal of the American Heart Association . 2019,第17期

机译：班加罗尔对文章的回应，“更新的超薄支撑药支架与较旧的第二代较厚的支撑支架，用于冠状动脉疾病：随机试验的Meta分析”
4. Potential of Curcumin as Antiproliferative Drug for Developing Drug Eluting Stent: A Brief Review [C] . Muhammad Kusumawan Herliansyah, Kholqillah Ardian Ilman, Alva Edy Tontowi, International Conference on Instrumentation, Communications, Information Technology, and Biomedical Engineering . 2017

机译：姜黄素作为抗增殖药开发药物洗脱支架的潜力：简要综述。
5. Drug diffusion and structural design criteria for conventional and auxetic drug-eluting stents. [D] . Dolla, William Jacob Spenner. 2006

机译：常规和生长不良药物洗脱支架的药物扩散和结构设计标准。
6. Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials [O] . Ping Zhu, Xin Zhou, Chenliang Zhang, 2018

机译：超薄支杆可生物降解聚合物西罗莫司洗脱支架与耐用聚合物药物洗脱支架的安全性和有效性：随机试验的荟萃分析
7. Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent [O] . Riccardo Improta, Paola Scarparo, Jeroen Wilschut, 2021

机译：冠状动脉总闭塞的弹性支架反冲：耐用聚合物Zotarimus的比较洗脱支架和超薄支撑生物吸收 - 聚合物Sirovimus洗脱支架

Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness polymeric carriers and antiproliferative drugs

著录项

相似文献

相关主题

期刊订阅